Shares of TrovaGene Inc. (NASDAQ: TROV), a developer of patented technology for the detection of transrenal DNA and RNA, have risen sharply in trading today.
Shares of TrovaGene Inc. (NASDAQ: TROV), a developer of patented technology for the detection of transrenal DNA and RNA, have risen sharply in trading today.